Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             111 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activated tumor cell integrin αvβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream Weber, Martin R.
 2016
 140 S1 p. S27-S36
10 p.
 artikel
2 Anticoagulants versus cancer Tieken, Chris
 2016
 140 S1 p. S148-S153
6 p.
 artikel
3 Author index 2016
 140 S1 p. S201-S203
3 p.
 artikel
4 Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy D’Asti, Esterina
 2016
 140 S1 p. S37-S43
7 p.
 artikel
5 Cancer associated thrombosis: risk factors and outcomes Eichinger, Sabine
 2016
 140 S1 p. S12-S17
6 p.
 artikel
6 Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review Bleker, Suzanne M.
 2016
 140 S1 p. S81-S88
8 p.
 artikel
7 Clinical practice guidelines on cancer-associated thrombosis: a review on scope and methodology Lee, Agnes Y.Y.
 2016
 140 S1 p. S119-S127
9 p.
 artikel
8 Copyright 2016
 140 S1 p. ii-
1 p.
 artikel
9 Editorial Board 2016
 140 S1 p. i-
1 p.
 artikel
10 Heparanase procoagulant activity in cancer progression Nadir, Yona
 2016
 140 S1 p. S44-S48
5 p.
 artikel
11 Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study Falanga, Anna
 2016
 140 S1 p. S55-S59
5 p.
 artikel
12 Incidental venous thromboembolic events in cancer patients: what we know in 2016 Liebman, Howard A.
 2016
 140 S1 p. S18-S20
3 p.
 artikel
13 Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes Brunson, Ann
 2016
 140 S1 p. S132-S141
10 p.
 artikel
14 Intracranial hemorrhage in cancer patients treated with anticoagulation Weinstock, Matthew J.
 2016
 140 S1 p. S60-S65
6 p.
 artikel
15 Laboratory determination of old and new targeted anticoagulant agents for prevention of bleeding and thrombotic events in cancer patients Harenberg, Job
 2016
 140 S1 p. S165-S167
3 p.
 artikel
16 LMWH in cancer patients with renal impairment – better than warfarin? Bauersachs, Rupert M.
 2016
 140 S1 p. S160-S164
5 p.
 artikel
17 Long-term arterial complications of chemotherapy in patients with cancer Svilaas, Tone
 2016
 140 S1 p. S109-S118
10 p.
 artikel
18 Management of bleeding complications in patients with cancer on DOACs Schulman, Sam
 2016
 140 S1 p. S142-S147
6 p.
 artikel
19 Management of cancer-associated disseminated intravascular coagulation Levi, Marcel
 2016
 140 S1 p. S66-S70
5 p.
 artikel
20 Management of recurrent venous thromboembolism in cancer patients Romualdi, Erica
 2016
 140 S1 p. S128-S131
4 p.
 artikel
21 Microparticles and cancer thrombosis in animal models Mege, Diane
 2016
 140 S1 p. S21-S26
6 p.
 artikel
22 Molecular biomarkers of thrombosis in myeloproliferative neoplasms Barbui, Tiziano
 2016
 140 S1 p. S71-S75
5 p.
 artikel
23 OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism Young, A.
 2016
 140 S1 p. S172-S173
2 p.
 artikel
24 OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin Piatek, C.I.
 2016
 140 S1 p. S174-
1 p.
 artikel
25 OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study Dentali, F.
 2016
 140 S1 p. S168-
1 p.
 artikel
26 OC-05 - D-Dimer, fibrinogen and TEG-MA predict thromboembolism in non-small cell lung cancer – interim results from a prospective cohort study Alexander, M.
 2016
 140 S1 p. S170-
1 p.
 artikel
27 OC-07 - Decoding risk for thromboembolic events in lymphoma patients Antic, D.
 2016
 140 S1 p. S171-
1 p.
 artikel
28 OC-10 - Disseminated intravascular coagulation at diagnosis strongly predicts both arterial and venous thrombosis in acute myeloid leukemia patients Libourel, E.J.
 2016
 140 S1 p. S172-
1 p.
 artikel
29 OC-09 - Microparticle-mediated transfer of TF hypercoagulability between cancer cells Shaker, H.
 2016
 140 S1 p. S172-
1 p.
 artikel
30 OC-03 - Modelisation of the procoagulant properties of cancer cells and their capacity to alter the antithrombotic efficiency of LMWHs and specific inhibitors of factor Xa Gerotziafas, G.T.
 2016
 140 S1 p. S169-
1 p.
 artikel
31 OC-08 - Multiple functional defects in platelets from thrombocytopenic cancer patients undergoing chemotherapy Baaten, C.C.F.M.J.
 2016
 140 S1 p. S171-
1 p.
 artikel
32 OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients? Hell, L.
 2016
 140 S1 p. S174-S175
2 p.
 artikel
33 OC-12 - Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice Petch, S.
 2016
 140 S1 p. S173-
1 p.
 artikel
34 OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer? Faille, D.
 2016
 140 S1 p. S170-S171
2 p.
 artikel
35 OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism Cosmi, B.
 2016
 140 S1 p. S174-
1 p.
 artikel
36 OC-02 - Risk of arterial thromboembolism in patients with breast cancer Navi, B.B.
 2016
 140 S1 p. S169-
1 p.
 artikel
37 OC-13 - Safe and effective use of direct oral anticoagulants (DOAC) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism Ross, J.A.
 2016
 140 S1 p. S173-S174
2 p.
 artikel
38 OC-04 - Tissue factor positive microvesicles activate platelets in vitro and in vivo and enhance thrombosis in mice Hisada, Y.
 2016
 140 S1 p. S169-S170
2 p.
 artikel
39 PO-29 - Age-adjusted D-dimer cutoff level increases the number of cancer patients in who pulmonary embolism can be safely excluded without CT-PA imaging: The ADJUST-PE cancer substudy Wilts, I.T.
 2016
 140 S1 p. S187-
1 p.
 artikel
40 PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy Martín, A.J. Muñoz
 2016
 140 S1 p. S177-S178
2 p.
 artikel
41 PO-42 - A novel approach to a common problem: after-hours care of cancer patients diagnosed with VTE Easaw, J.C.
 2016
 140 S1 p. S192-
1 p.
 artikel
42 PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1 Pinessi, D.
 2016
 140 S1 p. S182-
1 p.
 artikel
43 PO-16 - ASK1 regulates tumor lung metastasis and platelet functions Kamiyama, M.
 2016
 140 S1 p. S182-
1 p.
 artikel
44 PO-48 - Assessment of the procoagulant potential state of tumour-MP in cancer patients Algarni, A.
 2016
 140 S1 p. S194-
1 p.
 artikel
45 PO-49 - Bone microinfarction and microcirculation thrombosis; is it a possible mechanism for bone pain among cancer patients? Peled, E.
 2016
 140 S1 p. S194-S195
2 p.
 artikel
46 PO-06 - Cancer and the risk of venous thromboembolism in stroke patients Corraini, P.
 2016
 140 S1 p. S178-
1 p.
 artikel
47 PO-58 - Cardiovascular risk profile in survivors of adult cancer - results from the general population study Panova-Noeva, M.
 2016
 140 S1 p. S198-
1 p.
 artikel
48 PO-30 - Changes in soluble CD106 and CD54 serum levels during chemotherapy treatment for multiple myeloma Hall, J.
 2016
 140 S1 p. S187-
1 p.
 artikel
49 PO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer Kirwan, C.C.
 2016
 140 S1 p. S188-
1 p.
 artikel
50 PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia Alberelli, M.A.
 2016
 140 S1 p. S196-
1 p.
 artikel
51 PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients Königsbrügge, O.
 2016
 140 S1 p. S176-
1 p.
 artikel
52 PO-20 - Crosstalk between the lectin pathway and haemostasis in patients with pulmonary cancer Larsen, J.B.
 2016
 140 S1 p. S183-
1 p.
 artikel
53 PO-35 - Designing of the new antithrombotic and also anticancer gold complexes Benkli, K.
 2016
 140 S1 p. S189-
1 p.
 artikel
54 PO-24 - Determinants of thrombin generation in gynaecological malignancies Norris, L.A.
 2016
 140 S1 p. S185-
1 p.
 artikel
55 PO-43 - Differential coagulation factor expression in neuroendocrine prostate cancer (PC), metastatic castrate-resistant PC, and localized prostatic adenocarcinoma Choe, H.
 2016
 140 S1 p. S192-
1 p.
 artikel
56 PO-52 - Effect of tissue factor expression by colorectal cancer on cancer stem cell activity Clouston, H.W.
 2016
 140 S1 p. S195-S196
2 p.
 artikel
57 PO-07 - Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis van Es, N.
 2016
 140 S1 p. S179-
1 p.
 artikel
58 PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis Riedl, J.
 2016
 140 S1 p. S199-S200
2 p.
 artikel
59 PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer “gastric signet ring cell carcinoma” compared with that of other gastric cancers Fourgeaud, C.
 2016
 140 S1 p. S184-S185
2 p.
 artikel
60 PO-51 - Expression of proteins of the tissue factor thrombin pathway is upregulated in the stroma and epithelium of colorectal cancer Clouston, H.W.
 2016
 140 S1 p. S195-
1 p.
 artikel
61 PO-25 - FATCAT: an observational cohort study investigating fractal dimension (df) as a biomarker of thrombogenicity in cancer associated thrombosis during chemotherapy for lung cancer Davies, N.A.
 2016
 140 S1 p. S185-
1 p.
 artikel
62 PO-18 - Fibronectin EDA/EDB is expressed in adherent SCLC NCI-H69 cells and in pleural effusions of lung cancer patients: possible implication for drug resistance Salge-Bartels, U.
 2016
 140 S1 p. S182-S183
2 p.
 artikel
63 PO-59 - Hemorheologic disturbances as thrombosis risk factor in patients with some myeloproliferative neoplasms Roitman, E.V.
 2016
 140 S1 p. S198-
1 p.
 artikel
64 PO-33 - Heparin suppresses progression of small cell lung cancer (SCLC) in an orthotopic mouse model Taromi, S.
 2016
 140 S1 p. S188-
1 p.
 artikel
65 PO-17 - Identification of IgG bound to plasminogen in oncologic diseases Iakovlev, V.N.
 2016
 140 S1 p. S182-
1 p.
 artikel
66 PO-09 - Incidence of pre-operative and post-operative deep vein thrombosis in colorectal cancer surgery. Interim results of a prospective clinical study Clouston, H.W.
 2016
 140 S1 p. S179-S180
2 p.
 artikel
67 PO-05 - Incidence of venous thromboembolism (VTE) in bile duct tumors (BDT) treated with chemotherapy in ambulatory setting Adrián, S.G.
 2016
 140 S1 p. S178-
1 p.
 artikel
68 PO-55 - Individual variation in hemostatic alterations caused by tyrosine kinase inhibitors – a way to improve personalized cancer therapy? Deb, S.
 2016
 140 S1 p. S196-S197
2 p.
 artikel
69 PO-46 - Influence of extracellular vesicles derived from AML patients on stem cells and their microenvironment Tzoran, I.
 2016
 140 S1 p. S193-
1 p.
 artikel
70 PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL) Santi, R.M.
 2016
 140 S1 p. S177-
1 p.
 artikel
71 PO-10 - Lung cancer with tumour thrombosis: a poor prognosticator Tan, Z.K.
 2016
 140 S1 p. S180-
1 p.
 artikel
72 Polymorphisms of the coagulation system and risk of cancer Tinholt, Mari
 2016
 140 S1 p. S49-S54
6 p.
 artikel
73 PO-47 - Microparticles derived from ovarian cancer cell line contained genomic and biologically active proteins, including tissue factor involved in coagulation Besbes, S.
 2016
 140 S1 p. S194-
1 p.
 artikel
74 PO-34 - Optimal doses of tinzaparin to reduce both cancer-associated thrombosis and tumor growth in a mouse model of ectopic pancreatic syngeneic tumor Panicot-Dubois, L.
 2016
 140 S1 p. S189-
1 p.
 artikel
75 PO-37 - Optimization of the anticoagulant therapy in cancer patients Vorobev, A.
 2016
 140 S1 p. S190-
1 p.
 artikel
76 PO-61 - Patients’ Experiences of LIving with CANcer associated thrOmbosis in Spain (PELICANOS) Font, C.
 2016
 140 S1 p. S199-
1 p.
 artikel
77 PO-32 - Patient, tumour and operative factors influencing perioperative hypercoagulability in colorectal cancer Clouston, H.W.
 2016
 140 S1 p. S188-
1 p.
 artikel
78 PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status Vignoli, A.
 2016
 140 S1 p. S183-
1 p.
 artikel
79 PO-39 - Primary thromboprophylaxis for ambulatory patients with advanced metastatic pancreatic cancer. A practical implementation of lessons from published experience Bozas, G.
 2016
 140 S1 p. S191-
1 p.
 artikel
80 PO-57 - Problems of diagnostics of rare localizations thrombosis in cancer patients Vorobev, A.
 2016
 140 S1 p. S197-
1 p.
 artikel
81 PO-13 - Production of a functional thrombopoietin by a human ovarian cancer cell line Besbes, S.
 2016
 140 S1 p. S181-
1 p.
 artikel
82 PO-53 - Prospective evaluation of risk assessment models and biological markers of hypercoagulability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study Boura, P.
 2016
 140 S1 p. S196-
1 p.
 artikel
83 PO-28 - Protein C levels are associated with mortality in patients with advanced cancer Wilts, I.T.
 2016
 140 S1 p. S186-S187
2 p.
 artikel
84 PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort Mancuso, A.
 2016
 140 S1 p. S191-
1 p.
 artikel
85 PO-62 - Remote ischemic preconditioning in head and neck cancer reconstruction – a randomized controlled trial Krag, A.E.
 2016
 140 S1 p. S199-
1 p.
 artikel
86 PO-60 - Renal tumors with extensive vascular disease: management challenges in a pediatric series from the Hospital for Sick Children Zamperlini-Netto, G.
 2016
 140 S1 p. S198-S199
2 p.
 artikel
87 PO-02 - Retrospective audit of the Peripherally Inserted Central Catheter (PICC) associated thrombosis in patients with haematological malignancies at Cork University Hospital McAuliffe, E.
 2016
 140 S1 p. S176-
1 p.
 artikel
88 PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease Wells, P.S.
 2016
 140 S1 p. S191-S192
2 p.
 artikel
89 PO-21 - Stromal fibroblasts in preinvasive breast cancer (ductal carcinoma in situ, DCIS) demonstrate a cancer-like procoagulant phenotypic switch that may facilitate invasion Shaker, H.
 2016
 140 S1 p. S184-
1 p.
 artikel
90 PO-56 - Subsequent clot properties depend on the storage time of platelet concentrates Kolesnikova, I.M.
 2016
 140 S1 p. S197-
1 p.
 artikel
91 PO-50 - The effect of tissue factor expression on colorectal cancer cell proliferation Clouston, H.W.
 2016
 140 S1 p. S195-
1 p.
 artikel
92 PO-12 - The key role of talin-1 in cancer cell extravasation dissected through human vascularized 3D microfluidic model Gilardi, M.
 2016
 140 S1 p. S180-S181
2 p.
 artikel
93 PO-45 - The role of microvesicles in multiple myeloma progression Zarfati, M.
 2016
 140 S1 p. S193-
1 p.
 artikel
94 PO-11 - Thrombin and cancer stem-like cells: in vitro support for breast cancer anticoagulation Castle, J.
 2016
 140 S1 p. S180-
1 p.
 artikel
95 PO-27 - Thrombin generation in pancreatic cancer and multiple myeloma with use of calibrated automated thrombography Adesanya, M.A.
 2016
 140 S1 p. S186-
1 p.
 artikel
96 PO-36 - Thrombin Inhibition Preoperatively (TIP) in early breast cancer, the first clinical trial of NOACs as an anti-cancer agent: trial methodology Kirwan, C.C.
 2016
 140 S1 p. S189-S190
2 p.
 artikel
97 PO-22 - Thrombodynamics test for analysis of hemostasis in patients with malignant tumors and predicting thrombotic complications Vasilenko, I.
 2016
 140 S1 p. S184-
1 p.
 artikel
98 PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration Ghilardi, C.
 2016
 140 S1 p. S192-S193
2 p.
 artikel
99 PO-14 - Tumour expression of coagulation proteases of the aPC pathway – a role in the pathogenesis of gynaecological cancers? Martin, F.
 2016
 140 S1 p. S181-
1 p.
 artikel
100 PO-08 - Venous thrombosis and cancer: about an Algerian series Berrah-Bennaceur, M.
 2016
 140 S1 p. S179-
1 p.
 artikel
101 PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN) Giaccherini, C.
 2016
 140 S1 p. S185-S186
2 p.
 artikel
102 PO-38 - Young women with breast cancer and inferior vena cava thrombosis. Which is the best therapeutic option? And for how long? Vilaseca, A.B.
 2016
 140 S1 p. S190-
1 p.
 artikel
103 Predictors of recurrent venous thromboembolism and bleeding on anticoagulation Menapace, Laurel A.
 2016
 140 S1 p. S93-S98
6 p.
 artikel
104 Preface Falanga, Anna
 2016
 140 S1 p. ix-x
nvt p.
 artikel
105 Primary prophylaxis of VTE in cancer outpatients Imberti, Davide
 2016
 140 S1 p. S103-S108
6 p.
 artikel
106 Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors) Castaman, Giancarlo
 2016
 140 S1 p. S89-S92
4 p.
 artikel
107 Targeting clotting proteins in cancer therapy – progress and challenges Ruf, Wolfram
 2016
 140 S1 p. S1-S7
7 p.
 artikel
108 The International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) at the Peak of Adolescence – 15 Years and Counting Rickles, Frederick R.
 2016
 140 S1 p. S99-S102
4 p.
 artikel
109 The treatment of cancer associated thrombosis: does one size fit all? Who should get LMWH/warfarin/DOACs? Noble, Simon
 2016
 140 S1 p. S154-S159
6 p.
 artikel
110 Update of thrombosis in multiple myeloma Leebeek, Frank W.G.
 2016
 140 S1 p. S76-S80
5 p.
 artikel
111 Venous thromboembolism and occult cancer: impact on clinical practice Gheshmy, Afshan
 2016
 140 S1 p. S8-S11
4 p.
 artikel
                             111 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland